Aqueous suspension for nasal administration of loteprednol
Patent 6368616 Issued on April 9, 2002. Estimated Expiration Date: 
July 13, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
July 13, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesAqueous suspension of loteprednol etabonate Patent #: 5916550 InventorAssigneeApplicationNo. 341522 filed on 07/13/1999US Classes:424/434, Mucosal (e.g., nasal, etc.)514/781Cellulose or derivativeExaminersPrimary: Azpuru, CarlosAttorney, Agent or FirmForeign Patent References
International ClassA61F 013/00Foreign Application Priority Data1997-01-16 JPAbstractAn aqueous suspension for nasal administration which contains loteprednol etabonate and microcrystalline cellulose carmellose sodium. This aqueous suspension can be administered to nasal mucosa to treat inflammation or allergy. | |
